# Oral Supplementation With a Formulation Based on Cetylated Fatty Acids for Post-fracture Long Bone Healing

> **NCT07299851** · NA · RECRUITING · sponsor: **Pharmanutra S.p.a.** · enrollment: 100 (estimated)

## Conditions studied

- Fracture Femur
- Fracture Tibia

## Interventions

- **DIETARY_SUPPLEMENT:** CFA-based food supplement
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07299851
- **Lead sponsor:** Pharmanutra S.p.a.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-05
- **Final completion:** 2026-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07299851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07299851, "Oral Supplementation With a Formulation Based on Cetylated Fatty Acids for Post-fracture Long Bone Healing". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07299851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*